13F Holdings
中文EN

POCI PRECISION OPTICS CORPORATION, INC.

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 867840 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY53.0%
TTM net income YoY59.6%
TTM EPS YoY69.4%
Revenue 3-yr CAGR17.6%
Net income 3-yr CAGR—

Margins

Gross margin19.2%
Operating margin-7.4%
Net margin-7.5%
FCF margin—
EBITDA margin-6.5%

Returns

ROE-15.9%
ROA-9.3%
ROIC (approx.)-16.3%
Asset turnover1.25x

Leverage & solvency

Liabilities / assets34.0%
Debt / equity0.06x
Current ratio2.46x
Interest coverage-17.82x

Cash quality & payout

Operating cash flow / net income0.93x
Accruals ratio-0.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-06-30FY20252025-06-30FY20242024-06-30FY20232023-06-30FY20222022-06-30
Income statement
Revenue$31.53M$19.09M$19.10M$21.04M$15.68M
Cost of revenue$26.10M$15.69M$13.31M$13.31M$10.75M
Gross profit$5.43M$3.40M$5.80M$7.73M$4.93M
R&D expense$1.03M$1.16M$981,781$992,375$666,479
SG&A expense$7.91M$7.80M$7.54M$7.38M$5.61M
Operating income-$3.51M-$5.55M-$2.72M-$638,548-$1.51M
Interest expense$148,129$227,019$225,108$218,927$155,658
Pretax income-$3.62M-$5.78M-$2.95M-$142,677-$927,464
Income tax$4,958$1,936$1,936$1,936$952
Net income-$3.63M-$5.78M-$2.95M-$144,613-$928,416
EBITDA-$3.23M-$5.34M-$2.51M-$427,813-$1.32M
EPS (basic)-0.43-0.85-0.49-0.03-0.18
EPS (diluted)-0.43-0.85-0.49-0.03-0.18
Weighted avg. shares (diluted)8.53M6.79M6.07M5.67M5.30M
Balance sheet
Cash & equivalents$9.84M$1.77M$405,278$2.93M$605,749
Receivables$5.94M$4.34M$3.55M$3.91M$2.66M
Inventory$3.83M$3.56M$2.87M$2.78M$3.02M
Current assets$20.11M$10.06M$7.12M$9.86M$6.51M
PP&E, net$887,713$533,792$493,573$433,520$627,471
Goodwill$8.82M$8.82M$8.82M$8.82M$8.82M
Intangibles$212,889$232,493$286,559$265,111$229,398
Total assets$32.34M$19.79M$16.91M$19.74M$16.70M
Current liabilities$8.83M$6.15M$4.91M$5.26M$4.59M
Short-term debt$577,898$577,898$276,928$513,259$367,714
Long-term debt$711,305$1.29M$1.90M$2.18M$1.96M
Total debt$1.29M$1.87M$2.18M$2.69M$2.33M
Total liabilities$11.99M$7.53M$6.84M$7.69M$7.73M
Shareholders' equity$20.35M$12.26M$10.07M$12.05M$8.97M
Net debt-$8.55M$93,368$1.77M-$236,613$1.72M
Shares outstanding10.97M7.71M6.07M6.07M5.64M
Cash flow statement
Operating cash flow-$1.55M-$3.40M-$2.68M-$81,090-$933,371
Capital expenditure$426,786$227,209$272,435$16,784$113,197
Free cash flow-$1.98M-$3.62M-$2.96M-$97,874-$1.05M
Investing cash flow-$429,350-$233,473-$293,883-$52,497-$407,802
Financing cash flow$10.05M$5.00M$456,321$2.45M$1.09M
Depreciation & amortization$279,277$212,439$212,382$210,735$190,221
Stock-based compensation$1.14M$1.61M$959,784$919,032$915,494

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.